Update: 15.10.2024
Last week: 40 week 2024 (30.09.2024 - 06.10.2024)
Last full month: September 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 9 941 | 8.2% | 13.8% | 0.1 | 16 845 915 | 2.7% | 8.9% | -0.4 | 7.6% |
| MoM | 36 980 | 4.9% | 13.4% | -0.1 | 67 216 861 | 2.1% | 9.2% | -0.3 | 5.8% |
| YTD | 300 984 | 23.1% | 11.9% | 3.1 | 623 215 431 | 36.0% | 9.4% | 2 | -8.9% |
| MAT | 397 296 | 26.1% | 11.4% | 2.6 | 821 673 174 | 40.4% | 9.2% | 1.8 | -2.8% |
| BRAINMAX | |||||||||
| WoW | 2 470 | 27.3% | 100.0% | 0 | 8 489 097 | 27.4% | 100.0% | 0 | 27.3% |
| MoM | 7 570 | 10.4% | 100.0% | 0 | 26 517 643 | 8.2% | 100.0% | 0 | 10.4% |
| YTD | 51 699 | 62.6% | 100.0% | 0 | 182 174 751 | 68.1% | 100.0% | 0 | 62.6% |
| MAT | 66 560 | 71.7% | 100.0% | 0 | 234 819 080 | 79.8% | 100.0% | 0 | 71.7% |
| GOLDLINE PLUS | |||||||||
| WoW | 14 443 | -0.1% | 46.2% | -0.7 | 44 825 310 | -0.3% | 37.9% | -0.7 | 1.5% |
| MoM | 61 246 | -7.0% | 45.9% | 0.3 | 190 178 090 | -6.9% | 37.7% | 0.1 | -7.6% |
| YTD | 656 218 | -5.0% | 45.1% | 0.5 | 2 062 101 018 | -2.8% | 36.9% | -2.8 | -6.0% |
| MAT | 834 690 | -1.0% | 45.3% | 0.5 | 2 633 122 884 | 2.8% | 37.5% | -2.4 | -2.1% |
| MIGRENIUM | |||||||||
| WoW | 9 442 | -1.3% | 0.4% | 0 | 3 211 167 | -0.3% | 0.6% | 0 | -1.7% |
| MoM | 41 151 | -21.4% | 0.4% | -0.1 | 13 849 561 | -20.6% | 0.6% | -0.1 | -2.8% |
| YTD | 458 973 | -9.9% | 0.5% | -0.1 | 144 205 558 | 53.6% | 0.7% | 0.2 | 6.7% |
| MAT | 591 176 | -9.5% | 0.5% | -0.1 | 172 994 391 | 44.4% | 0.6% | 0.1 | 10.6% |
| MODELAX-N | |||||||||
| WoW | 26 682 | 4.0% | 21.1% | 0.1 | 12 591 256 | 2.9% | 13.9% | -0.1 | 3.5% |
| MoM | 107 577 | 0.1% | 20.6% | 1.1 | 50 949 280 | 1.1% | 13.5% | 0.7 | -5.3% |
| YTD | 1 136 672 | 30.2% | 22.4% | 3.6 | 497 671 009 | 79.6% | 14.5% | 4.1 | 9.2% |
| MAT | 1 431 761 | 40.5% | 21.4% | 4 | 603 317 310 | 84.8% | 13.5% | 3.7 | 14.3% |
| REDUXIN | |||||||||
| WoW | 9 966 | 1.3% | 31.9% | -0.1 | 51 678 565 | 2.3% | 43.8% | 0.3 | 1.5% |
| MoM | 42 769 | -9.5% | 32.1% | -0.7 | 220 075 387 | -8.9% | 43.7% | -0.8 | -7.6% |
| YTD | 477 393 | -7.6% | 32.8% | -0.6 | 2 538 599 660 | 12.1% | 45.4% | 3 | -6.0% |
| MAT | 598 369 | -4.9% | 32.5% | -1 | 3 146 753 005 | 16.0% | 44.8% | 2.6 | -2.1% |
| REDUXIN FORTE | |||||||||
| WoW | 3 222 | 9.0% | 10.3% | 0.7 | 13 514 324 | 6.4% | 11.4% | 0.5 | 1.5% |
| MoM | 13 776 | -1.3% | 10.3% | 0.7 | 58 932 380 | 0.6% | 11.7% | 0.9 | -7.6% |
| YTD | 131 494 | 1.3% | 9.0% | 0.7 | 566 679 323 | 12.9% | 10.1% | 0.8 | -6.0% |
| MAT | 167 725 | 7.1% | 9.1% | 0.8 | 718 412 726 | 18.8% | 10.2% | 0.8 | -2.1% |
| SALVISAR | |||||||||
| WoW | 10 851 | -3.5% | 1.4% | -0.1 | 4 655 538 | -3.4% | 1.3% | -0.1 | 2.0% |
| MoM | 47 722 | 21.0% | 1.5% | 0.3 | 20 388 247 | 20.6% | 1.3% | 0.2 | -2.4% |
| YTD | 402 932 | 5.1% | 1.4% | 0.1 | 165 718 989 | 31.5% | 1.2% | 0.1 | -2.2% |
| MAT | 517 828 | -5.1% | 1.3% | -0.1 | 203 464 342 | 11.6% | 1.1% | -0.1 | 2.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 300 984 | 23.1% | 11.9% | 3.1 | 623 215 431 | 36.0% | 9.4% | 2 | -8.9% |
| BRAINMAX | 51 699 | 62.6% | 100.0% | 0 | 182 174 751 | 68.1% | 100.0% | 0 | 62.6% |
| GOLDLINE PLUS | 656 218 | -5.0% | 45.1% | 0.5 | 2 062 101 018 | -2.8% | 36.9% | -2.8 | -6.0% |
| MIGRENIUM | 458 973 | -9.9% | 0.5% | -0.1 | 144 205 558 | 53.6% | 0.7% | 0.2 | 6.7% |
| MODELAX-N | 1 136 672 | 30.2% | 22.4% | 3.6 | 497 671 009 | 79.6% | 14.5% | 4.1 | 9.2% |
| REDUXIN CAPS | 477 393 | -7.6% | 32.8% | -0.6 | 2 538 599 660 | 12.1% | 45.4% | 3 | -6.0% |
| REDUXIN FORTE | 131 494 | 1.3% | 9.0% | 0.7 | 566 679 323 | 12.9% | 10.1% | 0.8 | -6.0% |
| SALVISAR | 402 932 | 5.1% | 1.4% | 0.1 | 165 718 989 | 31.5% | 1.2% | 0.1 | -2.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 397 296 | 26.1% | 11.4% | 2.6 | 821 673 174 | 40.4% | 9.2% | 1.8 | -2.8% |
| BRAINMAX | 66 560 | 71.7% | 100.0% | 0 | 234 819 080 | 79.8% | 100.0% | 0 | 71.7% |
| GOLDLINE PLUS | 834 690 | -1.0% | 45.3% | 0.5 | 2 633 122 884 | 2.8% | 37.5% | -2.4 | -2.1% |
| MIGRENIUM | 591 176 | -9.5% | 0.5% | -0.1 | 172 994 391 | 44.4% | 0.6% | 0.1 | 10.6% |
| MODELAX-N | 1 431 761 | 40.5% | 21.4% | 4 | 603 317 310 | 84.8% | 13.5% | 3.7 | 14.3% |
| REDUXIN CAPS | 598 369 | -4.9% | 32.5% | -1 | 3 146 753 005 | 16.0% | 44.8% | 2.6 | -2.1% |
| REDUXIN FORTE | 167 725 | 7.1% | 9.1% | 0.8 | 718 412 726 | 18.8% | 10.2% | 0.8 | -2.1% |
| SALVISAR | 517 828 | -5.1% | 1.3% | -0.1 | 203 464 342 | 11.6% | 1.1% | -0.1 | 2.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 9 941 | 8.2% | 13.8% | 0.1 | 16 845 915 | 2.7% | 8.9% | -0.4 | 7.6% |
| BRAINMAX | 2 470 | 27.3% | 100.0% | 0 | 8 489 097 | 27.4% | 100.0% | 0 | 27.3% |
| GOLDLINE PLUS | 14 443 | -0.1% | 46.2% | -0.7 | 44 825 310 | -0.3% | 37.9% | -0.7 | 1.5% |
| MIGRENIUM | 9 442 | -1.3% | 0.4% | 0 | 3 211 167 | -0.3% | 0.6% | 0 | -1.7% |
| MODELAX-N | 26 682 | 4.0% | 21.1% | 0.1 | 12 591 256 | 2.9% | 13.9% | -0.1 | 3.5% |
| REDUXIN CAPS | 9 966 | 1.3% | 31.9% | -0.1 | 51 678 565 | 2.3% | 43.8% | 0.3 | 1.5% |
| REDUXIN FORTE | 3 222 | 9.0% | 10.3% | 0.7 | 13 514 324 | 6.4% | 11.4% | 0.5 | 1.5% |
| SALVISAR | 10 851 | -3.5% | 1.4% | -0.1 | 4 655 538 | -3.4% | 1.3% | -0.1 | 2.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 36 980 | 4.9% | 13.4% | -0.1 | 67 216 861 | 2.1% | 9.2% | -0.3 | 5.8% |
| BRAINMAX | 7 570 | 10.4% | 100.0% | 0 | 26 517 643 | 8.2% | 100.0% | 0 | 10.4% |
| GOLDLINE PLUS | 61 246 | -7.0% | 45.9% | 0.3 | 190 178 090 | -6.9% | 37.7% | 0.1 | -7.6% |
| MIGRENIUM | 41 151 | -21.4% | 0.4% | -0.1 | 13 849 561 | -20.6% | 0.6% | -0.1 | -2.8% |
| MODELAX-N | 107 577 | 0.1% | 20.6% | 1.1 | 50 949 280 | 1.1% | 13.5% | 0.7 | -5.3% |
| REDUXIN CAPS | 42 769 | -9.5% | 32.1% | -0.7 | 220 075 387 | -8.9% | 43.7% | -0.8 | -7.6% |
| REDUXIN FORTE | 13 776 | -1.3% | 10.3% | 0.7 | 58 932 380 | 0.6% | 11.7% | 0.9 | -7.6% |
| SALVISAR | 47 722 | 21.0% | 1.5% | 0.3 | 20 388 247 | 20.6% | 1.3% | 0.2 | -2.4% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs